A comparative, randomised, masked, controlled trial to study structural and functional assessment of macula in patients with high-risk proliferative diabetic retinopathy.
Phase of Trial: Phase IV
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 27 Nov 2015 New trial record